Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by tamarindo1on Jan 21, 2021 5:32pm

273 Views

Post# 32355218

The next Quarterly?

The Dec 7 NR opening of UBC study site says to date 14 patients have been treated and as the last 2 NRs ref: the two USA sites also to date 14 patients have been treated, also last years first quarterly report was released on 7 Jan, I expect this coming quarterly report just may have some explosive news re-patients treated.
The Nova Scotia site was opened last Feb.25 and the province has been relatively covid19 free compared to other provinces hopefully we get some info from there.

I always like to look over the phase1 results for patients 5 and 6.
#5, july31/19.... 18 months cancer free.
#6 sep30/19......540 days, no tumor.

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks